IEEE Trans Biomed Eng. 2023 Dec;70(12):3461-3468. doi: 10.1109/TBME.2023.3289059. Epub 2023 Nov 21.
The study describes the development and testing of a dry surface stimulation flexible electrode (herein referred to as Flexatrode), a low-cost, flexible, and scalable elastomeric nanocomposite using carbon black (CB) and polydimethylsiloxane (PDMS).
Flexatrodes composed of CB and PDMS were developed and tested for mechanical and functional stability up to 7 days. Uniform CB distribution was achieved by optimizing the dispersion process using toluene and methyl-terminated PDMS. Electromechanical testing in the through thickness directions over a long-term duration demonstrated stability of Flexatrode. Thermal stability of Flexatrode for up to a week was tested and validated, thus mitigating concerns of heat generation and deleterious skin reactions such as vasodilation or erythema.
25 wt.% CB was determined to be the optimal concentration. Electrical and thermal stability were demonstrated in the through thickness direction.
Flexatrode provides stable electrical properties combined with high flexibility and elasticity. Electrotherapy treated chronic wounds were 81.9% smaller than baseline at day 10. Wounds that received an inactive device (device without any electrical stimulation) were 58.1% smaller than baseline and wounds that received standard of care treatment were 62.2% smaller than baseline.
The increasing need for wearable bioelectronics requiring long-term monitoring/treatment has highlighted the limitations of sustained use of gel-based electrodes. These can include skin irritation, bacterial overgrowth at the electrode site, gel dehydration over time, and signal degradation due to eccrine sweat formation. Flexatrode provides stable performance in a nanocomposite with scalable fabrication, thus providing a promising platform technology for wearable bioelectronics.
本研究描述了一种干燥表面刺激柔性电极(简称 Flexatrode)的开发和测试,该电极采用低成本、柔性且可扩展的弹性纳米复合材料,由炭黑(CB)和聚二甲基硅氧烷(PDMS)组成。
开发了由 CB 和 PDMS 组成的 Flexatrode,并对其机械和功能稳定性进行了长达 7 天的测试。通过优化使用甲苯和甲基封端 PDMS 的分散过程,实现了 CB 的均匀分布。在长时间内进行的贯穿厚度方向的机电测试证明了 Flexatrode 的稳定性。对 Flexatrode 进行了长达一周的热稳定性测试和验证,从而减轻了发热和有害皮肤反应(如血管扩张或红斑)的担忧。
确定 25wt.% CB 为最佳浓度。在贯穿厚度方向上展示了电和热稳定性。
Flexatrode 提供了稳定的电性能,同时具有高柔韧性和弹性。接受电疗的慢性伤口在第 10 天比基线缩小了 81.9%。接受无活性装置(无任何电刺激的装置)治疗的伤口比基线缩小了 58.1%,接受标准治疗的伤口比基线缩小了 62.2%。
对需要长期监测/治疗的可穿戴生物电子设备的需求不断增加,突出了基于凝胶的电极持续使用的局限性。这些局限性包括皮肤刺激、电极部位细菌过度生长、凝胶随时间脱水以及由于汗腺形成导致信号降级。Flexatrode 在具有可扩展制造的纳米复合材料中提供稳定的性能,因此为可穿戴生物电子学提供了一种有前途的平台技术。